Sintx Technologies Inc (SINT)

$2.27 -0.13 (-5.62%)
Market Cap 9.89M
Revenue (ttm) 1.02M
Net Income (ttm) -10.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,015.69%
Debt to Equity Ratio 0.00
Volume 30,400
Avg Vol 35,912
Day's Range N/A - N/A
Shares Out 4.12M
Stochastic %K 11%
Beta 0.61
Analysts Sell
Price Target $11.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
SnoopyDog
SnoopyDog May. 16 at 12:29 AM
$SINT so good, revenue increasing sharp with all the well payed executives onboard!
0 · Reply
Boston7452
Boston7452 May. 15 at 9:58 PM
$SINT "Silicon nitride–based wound management, suture, and soft-tissue applications · Biomaterial platforms intended for internal use and third-party licensing"
0 · Reply
Boston7452
Boston7452 May. 15 at 9:55 PM
$SINT Coming soon: "This role will be critical in supporting 3D-printed patient-specific implants, antipathogenic wound-management and soft-tissue technologies, and the commercial launch and lifecycle management of the SINERGY™ SiN/PEEK biomaterial."
1 · Reply
Boston7452
Boston7452 May. 15 at 9:12 PM
$SINT going to need a pump to trigger those outstanding warrants at 4.8.
0 · Reply
Boston7452
Boston7452 May. 15 at 9:08 PM
$SINT “The reports emerging this week of a major Ebola outbreak in the Democratic Republic of Congo, coming alongside a growing hantavirus outbreak linked to a cruise ship in South America, should serve as another warning that the era of emerging infectious diseases is not ahead of us. We are already living in it. According to Africa CDC, the Ebola outbreak in Ituri province has already resulted in 246 suspected cases and 65 deaths, with preliminary testing suggesting a non-Zaire ebolavirus strain”
0 · Reply
SnoopyDog
SnoopyDog May. 15 at 8:14 PM
$SINT financials today will be bombastico
1 · Reply
SnoopyDog
SnoopyDog May. 15 at 6:36 PM
$SINT this is a rock solid investment
0 · Reply
Boston7452
Boston7452 May. 15 at 6:26 PM
$SINT And yet Mgmt, Medtech, & Sinaptic own over 50% of Sintx fully diluted. I believe Medtech is an investment front for LDS church.
0 · Reply
FastBull
FastBull May. 15 at 5:59 PM
$SINT Garbage
0 · Reply
Boston7452
Boston7452 May. 15 at 4:10 PM
$SINT Current mgmt is capable but that doesnt mean its motivated to execute. Although Chris Lyons helped sell a company to Zimmer Biomet in 2024 before joining Sintx in 2025. Always someone connected to Zimmer Biomet on Sintx board.
1 · Reply
Latest News on SINT
Sintx Technologies initiated with a Buy at H.C. Wainwright

2026-04-13T10:11:23.000Z - 4 weeks ago

Sintx Technologies initiated with a Buy at H.C. Wainwright

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Mar 23, 2026, 9:15 AM EDT - 7 weeks ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

2026-03-19T11:51:39.000Z - 2 months ago

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Mar 19, 2026, 7:30 AM EDT - 2 months ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Sintx Technologies appoints Elmore as President

2026-02-18T13:40:31.000Z - 3 months ago

Sintx Technologies appoints Elmore as President

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Feb 18, 2026, 8:30 AM EST - 3 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Jan 29, 2026, 9:00 AM EST - 3 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Sintx Technologies signs supply agreement with EVONIK

2025-12-01T13:35:45.000Z - 5 months ago

Sintx Technologies signs supply agreement with EVONIK

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Dec 1, 2025, 8:30 AM EST - 5 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

2025-11-13T13:05:19.000Z - 6 months ago

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

Sintx Technologies announces launch of OsseoSculpt

2025-11-03T13:05:41.000Z - 6 months ago

Sintx Technologies announces launch of OsseoSculpt

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Nov 3, 2025, 8:00 AM EST - 6 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Sintx Technologies files to sell 1.74M shares of common stock for holders

2025-10-23T20:40:36.000Z - 7 months ago

Sintx Technologies files to sell 1.74M shares of common stock for holders

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

2025-10-20T11:05:38.000Z - 7 months ago

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 20, 2025, 7:00 AM EDT - 7 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Sintx Technologies announces U.S. patent notice of allowance

2025-10-14T11:11:00.000Z - 7 months ago

Sintx Technologies announces U.S. patent notice of allowance

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Oct 14, 2025, 7:00 AM EDT - 7 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Sintx Technologies files to sell 541,450 shares of common stock for holders

2025-09-30T20:55:10.000Z - 8 months ago

Sintx Technologies files to sell 541,450 shares of common stock for holders

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

2025-09-09T02:54:00.000Z - 8 months ago

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

2025-09-08T12:01:04.000Z - 8 months ago

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 8 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sintx Technologies receives USPTO notice of allowance

2025-09-08T11:25:37.000Z - 8 months ago

Sintx Technologies receives USPTO notice of allowance

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

2025-09-03T11:10:22.000Z - 9 months ago

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

Sintx Technologies issues business update following strategic realignment

2025-08-15T11:11:47.000Z - 9 months ago

Sintx Technologies issues business update following strategic realignment

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates

2025-08-04T11:20:10.000Z - 10 months ago

Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Sintx Technologies submits FDA 510k for silicon nitride foot, ankle devices

2025-07-22T11:10:59.000Z - 10 months ago

Sintx Technologies submits FDA 510k for silicon nitride foot, ankle devices

Sintx Technologies acquires SiNAPTIC surgical assets for $750,000 in shares

2025-06-24T12:40:21.000Z - 11 months ago

Sintx Technologies acquires SiNAPTIC surgical assets for $750,000 in shares

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 11 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Sintx Technologies announces strategic vision focused on expansion

2025-06-12T13:10:27.000Z - 1 year ago

Sintx Technologies announces strategic vision focused on expansion

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

Dec 21, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

Dec 19, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

SnoopyDog
SnoopyDog May. 16 at 12:29 AM
$SINT so good, revenue increasing sharp with all the well payed executives onboard!
0 · Reply
Boston7452
Boston7452 May. 15 at 9:58 PM
$SINT "Silicon nitride–based wound management, suture, and soft-tissue applications · Biomaterial platforms intended for internal use and third-party licensing"
0 · Reply
Boston7452
Boston7452 May. 15 at 9:55 PM
$SINT Coming soon: "This role will be critical in supporting 3D-printed patient-specific implants, antipathogenic wound-management and soft-tissue technologies, and the commercial launch and lifecycle management of the SINERGY™ SiN/PEEK biomaterial."
1 · Reply
Boston7452
Boston7452 May. 15 at 9:12 PM
$SINT going to need a pump to trigger those outstanding warrants at 4.8.
0 · Reply
Boston7452
Boston7452 May. 15 at 9:08 PM
$SINT “The reports emerging this week of a major Ebola outbreak in the Democratic Republic of Congo, coming alongside a growing hantavirus outbreak linked to a cruise ship in South America, should serve as another warning that the era of emerging infectious diseases is not ahead of us. We are already living in it. According to Africa CDC, the Ebola outbreak in Ituri province has already resulted in 246 suspected cases and 65 deaths, with preliminary testing suggesting a non-Zaire ebolavirus strain”
0 · Reply
SnoopyDog
SnoopyDog May. 15 at 8:14 PM
$SINT financials today will be bombastico
1 · Reply
SnoopyDog
SnoopyDog May. 15 at 6:36 PM
$SINT this is a rock solid investment
0 · Reply
Boston7452
Boston7452 May. 15 at 6:26 PM
$SINT And yet Mgmt, Medtech, & Sinaptic own over 50% of Sintx fully diluted. I believe Medtech is an investment front for LDS church.
0 · Reply
FastBull
FastBull May. 15 at 5:59 PM
$SINT Garbage
0 · Reply
Boston7452
Boston7452 May. 15 at 4:10 PM
$SINT Current mgmt is capable but that doesnt mean its motivated to execute. Although Chris Lyons helped sell a company to Zimmer Biomet in 2024 before joining Sintx in 2025. Always someone connected to Zimmer Biomet on Sintx board.
1 · Reply
SnoopyDog
SnoopyDog May. 14 at 5:57 PM
$SINT They have a lot of experience onboard. They have proven over the last few years that they can sell and make good deals for shareholders.
1 · Reply
SnoopyDog
SnoopyDog May. 14 at 4:22 PM
$SINT $SINT this will be a crazy good investment with competent management in place. Lots $$$ to be made
0 · Reply
SnoopyDog
SnoopyDog May. 14 at 2:45 PM
$SINT markets are very green today - also very good for $SINT
0 · Reply
Boston7452
Boston7452 May. 14 at 1:50 PM
$SINT that seems sarcastic about IP, but it really is worth over 1 bn. I estimate Sintx addressable markets, in aggregate are over 300bn. Antipathogenic & Ortho being the big two with wound healing being number 3.
1 · Reply
SnoopyDog
SnoopyDog May. 14 at 1:35 PM
$SINT melt down today before earnings?After earnings boom?Because IP worth billions? Can highly recommend! Highly
0 · Reply
Boston7452
Boston7452 May. 13 at 8:27 PM
$SINT Si3N4 can aid in wound healing by both preventing infection and by providing orthosilicic acid which “promotes wound healing by stimulating collagen synthesis, strengthening connective tissue, and reducing chronic inflammation.”
0 · Reply
SnoopyDog
SnoopyDog May. 13 at 6:32 PM
$SINT i think this has the potential to run and heal the world. Lets see Im in
1 · Reply
SnoopyDog
SnoopyDog May. 13 at 6:30 PM
$SINT is management waiting for the next market crash to raise money?
0 · Reply
Boston7452
Boston7452 May. 12 at 9:56 PM
$SINT at this juncture I bet, assuming this will become a pandemic virus, it’ll weaken around Summer Soltice and return this Fall.
0 · Reply
Boston7452
Boston7452 May. 12 at 9:43 PM
$SINT “WICHITA, Kan. (KWCH) - (KDHE), in coordination with the Centers for Disease Control and Prevention (CDC) and the local health department, is monitoring a trio “with a high-risk exposure to a person with confirmed Andes hantavirus.”
0 · Reply
Boston7452
Boston7452 May. 12 at 9:37 PM
$SINT “First suspected 'generation three' hantavirus case as Italian who 'sat alongside' woman on Dutch KLM flight before she died develops symptoms - amid fears virus has MUTATED”
1 · Reply
Boston7452
Boston7452 May. 12 at 4:12 PM
$SINT “WHO head tells countries to prepare for more hantavirus cases” https://www.theguardian.com/world/2026/may/12/who-head-warns-countries-prepare-more-hantavirus-cases
0 · Reply